BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 21969513)

  • 1. Fluorosis because of prolonged voriconazole therapy in a teenager with acute myelogenous leukemia.
    Skiles JL; Imel EA; Christenson JC; Bell JE; Hulbert ML
    J Clin Oncol; 2011 Nov; 29(32):e779-82. PubMed ID: 21969513
    [No Abstract]   [Full Text] [Related]  

  • 2. Fluoride excess and periostitis in transplant patients receiving long-term voriconazole therapy.
    Wermers RA; Cooper K; Razonable RR; Deziel PJ; Whitford GM; Kremers WK; Moyer TP
    Clin Infect Dis; 2011 Mar; 52(5):604-11. PubMed ID: 21239842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoride excess in coccidioidomycosis patients receiving long-term antifungal therapy: an assessment of currently available triazoles.
    Thompson GR; Bays D; Cohen SH; Pappagianis D
    Antimicrob Agents Chemother; 2012 Jan; 56(1):563-4. PubMed ID: 22005993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind trial on prophylactic voriconazole (VRC) or placebo during induction chemotherapy for acute myelogenous leukaemia (AML).
    Vehreschild JJ; Böhme A; Buchheidt D; Arenz D; Harnischmacher U; Heussel CP; Ullmann AJ; Mousset S; Hummel M; Frommolt P; Wassmer G; Drzisga I; Cornely OA
    J Infect; 2007 Nov; 55(5):445-9. PubMed ID: 17822770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Voriconazole-induced pancreatitis in a patient of acute myeloid leukemia and invasive aspergillosis.
    Philip A; Sivaprakasam P; Sagar TG; Ganesan P
    J Pediatr Hematol Oncol; 2012 Jul; 34(5):406. PubMed ID: 22713708
    [No Abstract]   [Full Text] [Related]  

  • 6. Torsades de pointes associated with voriconazole use.
    Philips JA; Marty FM; Stone RM; Koplan BA; Katz JT; Baden LR
    Transpl Infect Dis; 2007 Mar; 9(1):33-6. PubMed ID: 17313469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical images: voriconazole-induced periostitis deformans.
    Becce F; Malghem J; Lecouvet FE; Vande Berg BC; Omoumi P
    Arthritis Rheum; 2012 Oct; 64(10):3490. PubMed ID: 22777747
    [No Abstract]   [Full Text] [Related]  

  • 8. Breakthrough disseminated fusariosis in an immunocompromised patient on voriconazole therapy.
    Kim MS; Lee HM; Sung HS; Won CH; Chang SE; Lee MW; Choi JH; Moon KC
    Int J Dermatol; 2012 May; 51(5):621-3. PubMed ID: 21790547
    [No Abstract]   [Full Text] [Related]  

  • 9. Breakthrough zygomycosis during voriconazole treatment for invasive aspergillosis.
    Kobayashi K; Kami M; Murashige N; Kishi Y; Fujisaki G; Mitamura T
    Haematologica; 2004 Nov; 89(11):ECR42. PubMed ID: 15533847
    [No Abstract]   [Full Text] [Related]  

  • 10. Multifocal nodular periostitis associated with prolonged voriconazole therapy in a lung transplant recipient.
    Ayub A; Kenney CV; McKiernan FE
    J Clin Rheumatol; 2011 Mar; 17(2):73-5. PubMed ID: 21169844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of disseminated fusariosis with voriconazole in an acute lymphoblastic leukaemia patient.
    Labois A; Gray C; Lepretre S
    Mycoses; 2011 Dec; 54 Suppl 4():8-11. PubMed ID: 22126523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of periostitis secondary to voriconazole therapy in a heart transplant recipient.
    Wise SM; Wilson MA
    Clin Nucl Med; 2011 Mar; 36(3):242-4. PubMed ID: 21285691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photosensitivity in immunocompromised patients receiving long-term therapy with oral voriconazole.
    Frick MA; Soler-Palacín P; Martín Nalda A; Guarner ME; Nadal CF
    Pediatr Infect Dis J; 2010 May; 29(5):480-1. PubMed ID: 20431387
    [No Abstract]   [Full Text] [Related]  

  • 14. Adverse reactions to voriconazole.
    Boyd AE; Modi S; Howard SJ; Moore CB; Keevil BG; Denning DW
    Clin Infect Dis; 2004 Oct; 39(8):1241-4. PubMed ID: 15486850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Periostitis secondary to prolonged voriconazole therapy in lung transplant recipients.
    Wang TF; Wang T; Altman R; Eshaghian P; Lynch JP; Ross DJ; Belperio JA; Weigt SS; Saggar R; Gregson A; Kubak B; Saggar R
    Am J Transplant; 2009 Dec; 9(12):2845-50. PubMed ID: 19845595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of voriconazole and dose individualization.
    Lutsar I; Hodges MR; Tomaszewski K; Troke PF; Wood ND
    Clin Infect Dis; 2003 Apr; 36(8):1087-8. PubMed ID: 12684928
    [No Abstract]   [Full Text] [Related]  

  • 17. Voriconazole-induced periostitis causing arthralgias mimicking a flare of granulomatosis with polyangiitis.
    Gladue HS; Fox DA
    J Clin Rheumatol; 2013 Dec; 19(8):444-5. PubMed ID: 24263147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Voriconazole-associated phototoxicity.
    Riahi RR; Cohen PR
    Dermatol Online J; 2011 Feb; 17(2):15. PubMed ID: 21382298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral voriconazole versus intravenous low dose amphotericin B for primary antifungal prophylaxis in pediatric acute leukemia induction: a prospective, randomized, clinical study.
    Mandhaniya S; Swaroop C; Thulkar S; Vishnubhatla S; Kabra SK; Xess I; Bakhshi S
    J Pediatr Hematol Oncol; 2011 Dec; 33(8):e333-41. PubMed ID: 22042283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intra-articular injection of voriconazole for Fusarium solani arthritis after bone marrow transplantation.
    Kawashima N; Yoshida N; Matsushita N; Ito M; Matsumoto K; Kato K
    J Infect; 2012 Oct; 65(4):366-7. PubMed ID: 22705652
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.